Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet aggregation and aspirin response in type 1 diabetes
2024-520324-29-00Phase 2Authorised
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of aspirin in diabetes mellitus type 1 (T1D), diabetic glomerulosclerosis and atherosclerotic disease (2 cohorts), sponsored by Steno Diabetes Center Copenhagen. Planned start Jan 2025; status: authorised.
02
Drugs
aspirin
03
Conditions
diabetes mellitus type 1 (T1D)diabetic glomerulosclerosisatherosclerotic disease
Beyond the preview
Go deeper on 2024-520324-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520324-29-00.